The Therapy continues to be fairly new in terms of widespread acceptance, and it's often labeled as an "off-label" use for depression, meaning its use With this context hasn't been formally accepted by the FDA. This classification can make it challenging for Medicare to justify coverage. Produced by AxeChris This https://g.co/kgs/7Pv1MXH